tiprankstipranks
Trending News
More News >
ChemoMetec A/S (DE:CHY)
FRANKFURT:CHY
Germany Market

ChemoMetec A/S (CHY) Ratios

Compare
3 Followers

ChemoMetec A/S Ratios

DE:CHY's free cash flow for Q2 2025 was kr0.92. For the 2025 fiscal year, DE:CHY's free cash flow was decreased by kr and operating cash flow was kr0.50. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
4.97 4.13 2.57 3.40 3.53
Quick Ratio
3.76 3.19 2.08 2.98 3.00
Cash Ratio
3.01 2.66 1.52 2.09 2.03
Solvency Ratio
1.38 1.54 1.20 1.27 1.15
Operating Cash Flow Ratio
1.31 1.29 1.29 1.50 1.51
Short-Term Operating Cash Flow Coverage
96.92 152.47 172.55 182.27 169.85
Net Current Asset Value
kr 378.44Mkr 367.73Mkr 208.87Mkr 164.43Mkr 107.90M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.01 0.02 <0.01 0.01
Debt-to-Capital Ratio
<0.01 0.01 0.02 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.20 1.23 1.40 1.30 1.30
Debt Service Coverage Ratio
96.62 92.28 68.76 69.29 46.60
Interest Coverage Ratio
976.96 211.91 133.72 126.39 65.16
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.25 0.47 0.48 0.19 0.21
Net Debt to EBITDA
-1.56 -1.26 -0.93 -1.15 -1.03
Profitability Margins
Gross Profit Margin
90.13%88.97%89.70%90.12%90.57%
EBIT Margin
43.34%52.08%47.78%40.43%38.05%
EBITDA Margin
45.75%55.22%51.01%45.89%42.94%
Operating Profit Margin
43.83%51.88%47.35%41.27%36.18%
Pretax Profit Margin
43.29%51.84%47.44%40.10%35.46%
Net Profit Margin
33.41%40.20%37.23%31.43%27.63%
Continuous Operations Profit Margin
33.41%40.20%37.23%31.43%27.63%
Net Income Per EBT
77.18%77.56%78.47%78.37%77.93%
EBT Per EBIT
98.77%99.91%100.18%97.16%98.00%
Return on Assets (ROA)
20.14%27.15%31.81%25.62%22.49%
Return on Equity (ROE)
24.11%33.52%44.64%33.34%29.18%
Return on Capital Employed (ROCE)
30.92%42.79%55.75%42.51%35.96%
Return on Invested Capital (ROIC)
23.74%32.97%43.51%33.14%27.88%
Return on Tangible Assets
23.41%30.89%36.75%30.78%27.94%
Earnings Yield
2.60%2.20%1.21%0.60%1.11%
Efficiency Ratios
Receivables Turnover
5.90 8.11 6.16 4.49 4.83
Payables Turnover
3.63 2.79 2.59 3.19 2.39
Inventory Turnover
0.34 0.44 0.66 0.92 0.80
Fixed Asset Turnover
4.43 5.37 5.73 6.62 4.94
Asset Turnover
0.60 0.68 0.85 0.82 0.81
Working Capital Turnover Ratio
1.07 1.51 2.21 1.92 1.94
Cash Conversion Cycle
1.04K 753.16 470.80 362.52 377.34
Days of Sales Outstanding
61.82 45.03 59.25 81.34 75.59
Days of Inventory Outstanding
1.08K 838.83 552.32 395.61 454.16
Days of Payables Outstanding
100.46 130.70 140.77 114.43 152.41
Operating Cycle
1.14K 883.86 611.57 476.95 529.75
Cash Flow Ratios
Operating Cash Flow Per Share
7.41 8.86 10.16 6.20 4.27
Free Cash Flow Per Share
4.91 6.51 6.95 4.79 2.69
CapEx Per Share
2.50 2.35 3.21 1.41 1.59
Free Cash Flow to Operating Cash Flow
0.66 0.74 0.68 0.77 0.63
Dividend Paid and CapEx Coverage Ratio
0.87 3.78 1.41 2.13 0.19
Capital Expenditure Coverage Ratio
2.96 3.78 3.16 4.38 2.69
Operating Cash Flow Coverage Ratio
31.05 21.53 26.03 45.76 31.43
Operating Cash Flow to Sales Ratio
0.32 0.35 0.41 0.38 0.34
Free Cash Flow Yield
1.63%1.40%0.92%0.57%0.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
38.49 45.39 82.61 166.14 89.75
Price-to-Sales (P/S) Ratio
12.86 18.25 30.75 52.21 24.80
Price-to-Book (P/B) Ratio
9.28 15.21 36.88 55.40 26.19
Price-to-Free Cash Flow (P/FCF) Ratio
61.37 71.56 108.92 176.26 117.27
Price-to-Operating Cash Flow Ratio
40.66 52.61 74.49 136.04 73.74
Price-to-Earnings Growth (PEG) Ratio
-1.62 3.75 1.03 3.71 2.94
Price-to-Fair Value
9.28 15.21 36.88 55.40 26.19
Enterprise Value Multiple
26.55 31.79 59.36 112.64 56.74
Enterprise Value
EV to EBITDA
26.55 31.79 59.36 112.64 56.74
EV to Sales
12.14 17.55 30.28 51.69 24.36
EV to Free Cash Flow
57.95 68.83 107.25 174.49 115.18
EV to Operating Cash Flow
38.40 50.60 73.34 134.67 72.42
Tangible Book Value Per Share
27.05 26.05 16.65 11.90 8.98
Shareholders’ Equity Per Share
32.48 30.63 20.53 15.23 12.03
Tax and Other Ratios
Effective Tax Rate
0.23 0.22 0.22 0.22 0.22
Revenue Per Share
23.44 25.54 24.62 16.15 12.70
Net Income Per Share
7.83 10.27 9.16 5.08 3.51
Tax Burden
0.77 0.78 0.78 0.78 0.78
Interest Burden
1.00 1.00 0.99 0.99 0.93
Research & Development to Revenue
0.00 0.01 0.01 0.02 0.03
SG&A to Revenue
0.00 0.00 0.10 0.08 0.12
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.95 0.67 0.87 0.93 0.93
Currency in DKK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis